AZN News and Press, AstraZeneca PLC From 12/31/23

2023-12-31 01:55:00 ET Summary Elpiscience Biopharma forms a $1.7 billion collaboration with Astellas Pharma to develop a bispecific macrophage engager. AstraZeneca acquires Gracell Biotech in a deal worth up to $1.2 billion, including a clinical stage CAR-T therapy. Jinan Qil...

2023-12-28 15:06:23 ET More on AbbVie, Amgen, etc. The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovations Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Bristol Myers Squibb: Too Many Headwinds To Ignore, Despit...

2023-12-28 08:02:48 ET More on Cytosorbents Cytosorbents Corporation (CTSO) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Cytosorbents Historical earnings data for Cytosorbents Financial information for Cytosorbents For furth...

2023-12-27 16:11:16 ET Summary Gracell Biotechnologies has seen a 360% increase in its stock price YTD, with a particular boost since AstraZeneca decided to acquire it for USD $1.2 billion. The acquisition price sounds fair, and the run-up following the announcement leaves little ...

2023-12-27 12:29:36 ET More on AbbVie, Johnson & Johnson, etc. Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) AbbVie Vs. GSK: Dual Dominance In Pharma ...

2023-12-27 10:29:37 ET More on Cytokinetics Cytokinetics: Clear Win For Aficamten In SEQUOIA-HCM Phase 3 Trial (Upgrade) Cytokinetics: Buyout Rumors Ahead Of The Key Phase 3 Readout Of Aficamten Cytokinetics, Incorporated (CYTK) Q3 2023 Earnings Call Transcript ...

2023-12-27 10:00:08 ET Summary Cytokinetics' share price surged after announcing positive results from the phase 3 SEQUOIA-HCM trial of aficamten. Aficamten showed better efficacy, safety, and convenience compared to Camzyos, positioning it as a potential best-in-class drug. T...

2023-12-26 07:02:44 ET More on BioNTech, Moderna, etc. BioNTech's COVID-19 Success Paves The Way For A Strong Drug Pipeline Pfizer: Buy The Panic Pfizer Is Not Cheap, And The 5.7% Yield Is Not As Safe As You Might Think Citi puts Pfizer on catalyst watch afte...

2023-12-26 06:47:11 ET Summary AstraZeneca to acquire China-based Gracell Biotechnologies for up to $1.2 billion. Manchester United sells 25% stake to billionaire Jim Ratcliffe for $1.3 billion. Nano Dimension submits all-cash proposal to buy Stratasys for $16.50 a share. ...

2023-12-26 05:24:51 ET U.S. stock future on Tuesday edged higher on Tuesday to start the holiday-shortened week. The major averages are expected to extend their winning streak until the end of the year, as further signs of cooling US inflation reinforced bets that the Federal R...